These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16650874)

  • 1. Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?
    Kutzelnigg A; Lassmann H
    J Neurol Sci; 2006 Jun; 245(1-2):123-6. PubMed ID: 16650874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.
    Bö L; Geurts JJ; van der Valk P; Polman C; Barkhof F
    Arch Neurol; 2007 Jan; 64(1):76-80. PubMed ID: 17210812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
    Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis.
    Bagnato F; Salman Z; Kane R; Auh S; Cantor FK; Ehrmantraut M; Gallo A; Ikonomidou VN; Ohayon J; Pellicano C; Stern SK; McFarland HF
    Mult Scler; 2010 Oct; 16(10):1203-12. PubMed ID: 20699284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
    Kutzelnigg A; Lucchinetti CF; Stadelmann C; Brück W; Rauschka H; Bergmann M; Schmidbauer M; Parisi JE; Lassmann H
    Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
    Kooi EJ; Geurts JJ; van Horssen J; Bø L; van der Valk P
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):1021-8. PubMed ID: 19680141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical pathology and cognitive impairment in multiple sclerosis.
    Calabrese M; Rinaldi F; Grossi P; Gallo P
    Expert Rev Neurother; 2011 Mar; 11(3):425-32. PubMed ID: 21375447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical atrophy and personality in multiple sclerosis.
    Benedict RH; Hussein S; Englert J; Dwyer MG; Abdelrahman N; Cox JL; Munschauer FE; Weinstock-Guttman B; Zivadinov R
    Neuropsychology; 2008 Jul; 22(4):432-41. PubMed ID: 18590355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical lesions and brain atrophy in MS.
    Kutzelnigg A; Lassmann H
    J Neurol Sci; 2005 Jun; 233(1-2):55-9. PubMed ID: 15893328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activated C4d immunoreactive oligodendrocytes delineate small cortical plaques in multiple sclerosis.
    Schwab C; McGeer PL
    Exp Neurol; 2002 Mar; 174(1):81-8. PubMed ID: 11869036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia.
    Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
    Neurology; 2007 Mar; 68(12):927-31. PubMed ID: 17372128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of cortical lesions in MS: relation with cognitive impairment.
    Roosendaal SD; Moraal B; Pouwels PJ; Vrenken H; Castelijns JA; Barkhof F; Geurts JJ
    Mult Scler; 2009 Jun; 15(6):708-14. PubMed ID: 19435749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction.
    Rovaris M; Comi G; Filippi M
    J Neurol Sci; 2006 Jun; 245(1-2):111-6. PubMed ID: 16626748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiorespiratory fitness: A predictor of cortical plasticity in multiple sclerosis.
    Prakash RS; Snook EM; Erickson KI; Colcombe SJ; Voss MW; Motl RW; Kramer AF
    Neuroimage; 2007 Feb; 34(3):1238-44. PubMed ID: 17134916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Movement disorders in multiple sclerosis: Causal or coincidental association?
    Nociti V; Bentivoglio AR; Frisullo G; Fasano A; Soleti F; Iorio R; Loria G; Patanella AK; Marti A; Tartaglione T; Tonali PA; Batocchi AP
    Mult Scler; 2008 Nov; 14(9):1284-7. PubMed ID: 18768580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional hippocampal atrophy in multiple sclerosis.
    Sicotte NL; Kern KC; Giesser BS; Arshanapalli A; Schultz A; Montag M; Wang H; Bookheimer SY
    Brain; 2008 Apr; 131(Pt 4):1134-41. PubMed ID: 18375977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of cortical multiple sclerosis.
    Zarei M
    J Neurol Sci; 2006 Jun; 245(1-2):53-8. PubMed ID: 16626743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis and Alzheimer's disease.
    Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
    Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.